Phase I – II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 study.

Focan C, Kreutz F, Graas MP, Longrée L, Focan-Henrard D, Demolin G, Moeneclaey N. Pathol Biol (Paris). 2013 Apr;61(2):e27-31. doi: 10.1016/j.patbio.2010.12.005. Epub 2012 Oct 25.

Voir l’article

Retour aux publications